Related Experiment Video
Updated: May 12, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Novel roles of complement in renal diseases and their therapeutic consequences
Takehiko Wada1, Masaomi Nangaku
1Division of Nephrology and Endocrinology, University of Tokyo School of Medicine, Bunkyo-ku, Tokyo, Japan.
Insights
The complement system, part of innate immunity, can harm kidneys if improperly activated. New research clarifies its role in kidney diseases and introduces novel diagnostic tools.
Area of Science:
- Immunology
- Nephrology
- Molecular Biology
Background:
- The complement system is a key component of innate immunity.
- Dysregulation of complement pathways can lead to kidney damage.
- Recent research highlights the complement system's role in glomerular and tubulointerstitial injury.
Purpose of the Study:
- To review recent advances in understanding complement system's role in kidney diseases.
- To discuss the pathogenesis of complement-mediated kidney conditions, including C3 glomerulopathy.
- To explore diagnostic and therapeutic developments in complement-related nephropathies.
Main Methods:
- Review of recent scientific literature on complement system and kidney disease.
- Analysis of genetic and functional studies implicating complement dysregulation.
- Evaluation of novel diagnostic techniques, such as MRI-based C3 detection.
- Examination of findings from genetically modified animal models.
Main Results:
- Inappropriate complement activation causes kidney injury.
- C3 glomerulopathy is a newly proposed entity characterized by isolated C3 deposition.
- Complement dysregulation is linked to various kidney diseases, including IgA nephropathy and diabetic kidney disease.
- A noninvasive MRI-based method for C3 detection has been developed.
Conclusions:
- The complement system plays a significant role in the pathogenesis of various kidney diseases.
- Understanding complement dysregulation is crucial for diagnosing and treating these conditions.
- Emerging diagnostic and therapeutic strategies offer new hope for managing complement-mediated kidney diseases.
Abstract:
The complement system functions as a part of the innate immune system. Inappropriate activation of the complement pathways has a deleterious effect on kidneys. Recent advances in complement research have provided new insights into the pathogenesis of glomerular and tubulointerstitial injury associated with complement activation. A new disease entity termed 'C3 glomerulopathy' has recently been proposed and is characterized by isolated C3 deposition in glomeruli without positive staining for immunoglobulins. Genetic and functional studies have demonstrated that several different mutations and disease variants, as well as the generation of autoantibodies, are potentially associated with its pathogenesis. The data from comprehensive analyses suggest that complement dysregulation can also be associated with hemolytic uremic syndrome and more common glomerular diseases, such as IgA nephropathy and diabetic kidney disease. In addition, animal studies utilizing genetically modified mice have begun to elucidate the molecular pathomechanisms associated with the complement system. From a diagnostic point of view, a noninvasive, MRI-based method for detecting C3 has recently been developed to serve as a novel tool for diagnosing complement-mediated kidney diseases. While novel therapeutic tools related to complement regulation are emerging, studies evaluating the precise roles of the complement system in kidney diseases will still be useful for developing new therapeutic approaches.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Complement System
Acute Kidney Injury III: Clinical Manifestations
